MedPath

Healthy Eating Better Breathing: A Feeding Study in Patients With Asthma

Not Applicable
Completed
Conditions
Asthma
Interventions
Other: healthy diet
Registration Number
NCT02904655
Lead Sponsor
Johns Hopkins University
Brief Summary

The study is a randomized, crossover meal-replacement pilot intervention to determine feasibility of a larger scale dietary trial in asthma and gather preliminary evidence for the impact of a healthy diet on asthma outcomes. Participants with doctor-diagnosed asthma were randomized to crossover trial of a 4-week dietary intervention or usual diet with a 4-week washout period. During the dietary intervention, all meals and snacks were provided by the study.

Detailed Description

The objective of the study is to demonstrate feasibility of a randomized, controlled clinical trial of a dietary intervention in a population of adults with asthma and to determine sample size estimates for a larger, more definitive trial aimed at improving asthma clinical outcomes and improving markers of inflammation and oxidative stress. The study uses a feeding trial design comprised of a 4 week dietary intervention in which all meals are provided to study participants and a 4 week control diet comprised of usual dietary intake. Participants are randomized to the intervention or control diet and then cross over to the alternate assignment after a 4 week washout period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • ages 18-50, self-reported physician diagnosis and treatment for asthma within the 12 months prior to enrollment, stable asthma defined as no asthma exacerbation (emergency department visit, systemic steroid treatment, or urgent care visit) or respiratory infection in the 4 weeks prior to enrollment.
Exclusion Criteria
  • active smokers,pregnant or breastfeeding, using systemic corticosteroids or warfarin, had another major pulmonary diagnosis or significant systemic illness, reported excessive alcohol consumption (over 14 drinks per week or six or more drinks on one or more occasions per week), reported food allergy, or weighed over 350 pounds or changed weight by over ten pounds in the two months prior to screening

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
healthy diethealthy dietParticipants were provided all meals and snacks for four weeks. Menus were created to target a healthy diet high in unsaturated fats.
Primary Outcome Measures
NameTimeMethod
Feasibility as assessed by the number of participant drop outsChange from baseline and 4 weeks

Feasibility will be assessed by the number of drop outs.

Adherence assessed by serum carotenoidsChange from baseline to 4 weeks

Serum carotenoids will be measured at baseline and at 4 weeks. An increase in serum carotenoids is expected with adherence to the dietary intervention.

Adherence using 24 hour diet recallChange from baseline to 4 weeks

Adherence to the dietary intervention will be assessed using self-report of dietary intake via 24 hour dietary recall.

Secondary Outcome Measures
NameTimeMethod
FEV1Difference between baseline and 2 weeks

Spirometry will be measured according to the American Thoracic Society standards. The forced expiratory volume in one second (FEV1) will be assessed and compared between baseline and 2 weeks after the dietary intervention

FVCDifference between baseline and 4 weeks

Spirometry will be measured according to the American Thoracic Society standards. The forced vital capacity (FVC) will be assessed and compared between baseline and 4 weeks after the dietary intervention

Asthma statusDifference between baseline and 2 weeks

Asthma Control Test (ACT, range 5-25, higher score denoting better asthma control). The change in score between baseline and week 2 will be assessed.

Asthma Quality of Life Questionnaire (AQLQ)Difference between baseline and 2 weeks

Asthma Quality of Life Questionnaire (AQLQ) is a 32 item questionnaire and each question uses a 7-point Likert scale (7 = not impaired at all - 1 = severely impaired). Scores between week 0 (baseline) and week 2 will be assessed.

FEV1/FVC ratioDifference between baseline and 2 weeks

Spirometry will be measured according to the American Thoracic Society standards. The forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio will be assessed and compared between baseline and 2 weeks after the dietary intervention

Exhaled nitric oxideDifference between baseline and 2 weeks

Exhaled nitric oxide is an indicator of airway inflammation and will be measured according to American Thoracic Society standards at baseline and 2 weeks.

Adherence assessed by serum carotenoidsDifference between baseline and 2 weeks

Serum carotenoids will be measured at baseline and at 4 weeks. An increase in serum carotenoids is expected with adherence to the dietary intervention.

Asthma Symptom Utility IndexDifference between baseline and 2 weeks

Asthma Symptom Utility Index (ASUI, range 0-1, higher score denoting fewer symptoms) will be measured and the difference between week 2 and week 0 (baseline) will be assessed.

© Copyright 2025. All Rights Reserved by MedPath